Exposing Hidden Targets: Combining epigenetic and immunotherapy to overcome cancer resistance. [electronic resource]
Producer: 20210608Description: 114-122 p. digitalISSN:- 1096-3650
- Antineoplastic Agents -- immunology
- B7-H1 Antigen -- adverse effects
- CTLA-4 Antigen -- antagonists & inhibitors
- Combined Modality Therapy
- Epigenesis, Genetic -- immunology
- Epigenetic Repression -- immunology
- Humans
- Immunotherapy -- adverse effects
- Neoplasms -- immunology
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.